Medicine & Health

WashU Medicine faculty and research members of Siteman Cancer Center have identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.

WashU Medicine infectious diseases expert Michael Diamond, MD, PhD, has won a $2.5 million prize to advance the development of drugs to treat debilitating chikungunya and related viruses.

A new study led by researchers at Olin Business School at Washington University in St. Louis finds private equity only accounts for a small share of the nation’s hospitals, with most investors exiting within five years.

Economist David Spielman brings global expertise in food policy and agricultural innovation to Bursky Public Health, advancing research connecting food systems and health.

The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials.

A study in mice by WashU Medicine researchers advances efforts to shield infants from Klebsiella pneumoniae, a dangerous bacterium that causes severe bloodstream infections and is the leading killer of children globally.

WashU Medicine psychiatry researcher Jan Kubanek was recognized with the One Mind Rising Star Award for his work on applying ultrasound to map and modulate brain circuits involved in depression.

A study led by Laura Marks, MD, and Madeline McCrary, MD, of WashU Medicine, shows that an oral antiviral regimen can be used safely and effectively in pregnant patients with hepatitis C virus.

WashU Medicine researchers have discovered that the ratio between two types of white blood cells can predict whether a person stays healthy as they age or faces an increased risk of disease.

A state-of-the-art facility expands community access to physical therapy services from orthopedic surgery recovery to golf swing mechanics.